BAY3401016; Biomarker Study Alport
NCT07211685
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Alport Syndrome
Interventions
BIOLOGICAL:
BAY 3401016
OTHER:
Placebo
Sponsor
Bayer